DK238384D0 - Farmaceutisk middel indeholdende methylsulfonylmethan - Google Patents

Farmaceutisk middel indeholdende methylsulfonylmethan

Info

Publication number
DK238384D0
DK238384D0 DK2383/84A DK238384A DK238384D0 DK 238384 D0 DK238384 D0 DK 238384D0 DK 2383/84 A DK2383/84 A DK 2383/84A DK 238384 A DK238384 A DK 238384A DK 238384 D0 DK238384 D0 DK 238384D0
Authority
DK
Denmark
Prior art keywords
methylsulphonylmethan
pharmaceutical composition
composition containing
methylsulfonylmethane
gastrointestinal upset
Prior art date
Application number
DK2383/84A
Other languages
Danish (da)
English (en)
Other versions
DK238384A (da
Inventor
Robert J Herschler
Original Assignee
Herschler R J
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Herschler R J filed Critical Herschler R J
Publication of DK238384A publication Critical patent/DK238384A/da
Publication of DK238384D0 publication Critical patent/DK238384D0/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DK2383/84A 1982-09-14 1984-05-14 Farmaceutisk middel indeholdende methylsulfonylmethan DK238384D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/418,110 US4514421A (en) 1979-08-30 1982-09-14 Dietary and pharmaceutical uses of methylsulfonylmethane and compositions comprising it
PCT/US1983/001396 WO1984001105A1 (en) 1982-09-14 1983-09-13 Dietary and pharmaceutical uses of methylsulfonylmethane and compositions comprising it

Publications (2)

Publication Number Publication Date
DK238384A DK238384A (da) 1984-05-14
DK238384D0 true DK238384D0 (da) 1984-05-14

Family

ID=23656756

Family Applications (1)

Application Number Title Priority Date Filing Date
DK2383/84A DK238384D0 (da) 1982-09-14 1984-05-14 Farmaceutisk middel indeholdende methylsulfonylmethan

Country Status (13)

Country Link
US (1) US4514421A (ru)
EP (1) EP0103836B1 (ru)
JP (1) JPS59501748A (ru)
AT (1) ATE60234T1 (ru)
AU (2) AU564536B2 (ru)
CA (1) CA1219218A (ru)
DE (1) DE3382136D1 (ru)
DK (1) DK238384D0 (ru)
NO (1) NO841909L (ru)
NZ (1) NZ205571A (ru)
PH (1) PH20568A (ru)
SU (1) SU1443788A3 (ru)
WO (1) WO1984001105A1 (ru)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863748A (en) * 1979-08-30 1989-09-05 Herschler R J Dietary products and uses comprising methylsulfonylmethane
US4514421A (en) * 1979-08-30 1985-04-30 Herschler R J Dietary and pharmaceutical uses of methylsulfonylmethane and compositions comprising it
US4914135A (en) * 1979-08-30 1990-04-03 Herschler R J Use of Methylsulfonylmethane to treat parasitic infections
US4616039A (en) * 1979-08-30 1986-10-07 Herschler R J Methylsulfonylmethane in dietary products
WO1994005293A1 (en) * 1992-09-04 1994-03-17 Aws Shakir Mustafa Salim Skin treatment compositions containing dimethylsulphone and allopurinol or oxypurinol
GB9218711D0 (en) * 1992-09-04 1992-10-21 Salim Aws S M Skin cancer treatment
US5834002A (en) 1994-05-02 1998-11-10 Josman Laboratories, Inc. Chewing gum containing colloidal bismuth subcitrate
US6426085B1 (en) 1994-05-02 2002-07-30 Josman Laboratories Inc. Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis
US6902738B2 (en) * 1994-05-02 2005-06-07 Josman Laboratories, Inc. Topical oral dosage forms containing bismuth compounds
US5569679A (en) * 1994-12-30 1996-10-29 Russell A. Krueger Pharmaceuticals, Inc. Pharmacologic management of snoring
US6372784B1 (en) 1995-02-07 2002-04-16 Josman Laboratories, Inc. Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds
US6379651B1 (en) 1995-02-07 2002-04-30 Josman Laboratories Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases
AU5733596A (en) * 1995-05-09 1996-11-29 Procter & Gamble Company, The Compositions containing bismuth, for the treatment and preve ntion of gastrointestinal disorders
EP0879035B1 (en) * 1995-08-24 2006-06-14 Josman Laboratories, Inc. Bismuth-containing compositions in topical dosage forms
DE69618617T2 (de) * 1995-12-07 2002-09-19 Procter & Gamble Wismuth enthaltende zusammensetzungen zur verhütung und behandlung gastrointestinaler beschwerden
US5744168A (en) * 1995-12-07 1998-04-28 The Procter & Gamble Company Methods and compositions for the prevention and treatment of gastrointestinal disorders
US5827543A (en) * 1995-12-07 1998-10-27 The Procter & Gamble Company Methods and compositions for the prevention and treatment of urogenital disorders
DK0776665T3 (da) * 1995-12-07 2003-03-31 Procter & Gamble Præparater til forebyggelse og behandling af urogenitale lidelser indeholdende bismuth
US6051604A (en) * 1995-12-07 2000-04-18 The Proctor & Gamble Company Methods and compositions for the prevention and treatment of gastrointestinal disorders
US5702729A (en) * 1995-12-07 1997-12-30 The Procter & Gamble Company Methods for the prevention and treatment of gastrointestinal disorders caused or mediated by algae or cyanobacteria
US7718694B2 (en) * 1997-10-16 2010-05-18 Children's Hospital & Research Center At Oakland Compositions and methods for therapy for diseases characterized by defective chloride transport
US6203820B1 (en) 1998-05-28 2001-03-20 Brice E. Vickery Compositions and methods for enhancing protein anabolism and detoxification
DE60033830T2 (de) * 1999-10-04 2007-11-15 John Harrow Carter Pharmazeutische zusammensetzung, die kupfer, salicylsäure und vitamin c enthält
US6793942B2 (en) 2000-02-23 2004-09-21 Bioselect Innovations, Inc. Composition and method for treating the effects of diseases and maladies
US6787164B2 (en) 2000-02-23 2004-09-07 Bioselect Innovations, Inc. Composition and method for treating the effects of diseases and maladies
US6759062B2 (en) 2000-02-23 2004-07-06 Bioselect Innovations, Inc. Composition and method for treating the effects of diseases and maladies
US6841544B2 (en) * 2000-02-23 2005-01-11 Bioselect Innovations, Inc. Composition and method for treating the effects of diseases and maladies
US6403116B1 (en) 2000-11-03 2002-06-11 Triarco Inductries, Inc. Coenzyme Q10 formulation
US20040038864A1 (en) * 2002-06-27 2004-02-26 Per Balschmidt Use of dimethyl sulfone as isotonicity agent
US20040029774A1 (en) * 2002-08-06 2004-02-12 Aly Gamay Composition and methods for the treatment of musculoskeletal disorders and collagen and elastin deficiencies
US20040082667A1 (en) * 2002-10-16 2004-04-29 Mccadden Kenneth Hangover treatment
JP2005298412A (ja) * 2004-04-13 2005-10-27 Minato Pharmaceutical Co Ltd 被覆粒子
JPWO2005112667A1 (ja) * 2004-05-20 2008-03-27 隆史 大森 健康食品
ITBS20040068A1 (it) * 2004-05-24 2004-08-24 Gen Topics Srl Composizione cosmetica e/o farmaceutica per il trattamento della rosacea
US20060147423A1 (en) * 2004-12-07 2006-07-06 Jean-Yves Legendre Transungual device
US8435224B2 (en) 2005-09-12 2013-05-07 Abela Pharmaceuticals, Inc. Materials for facilitating administration of dimethyl sulfoxide (DMSO) and related compounds
AU2006291134C1 (en) 2005-09-12 2013-08-15 Abela Pharmaceuticals, Inc. Systems for removing dimethyl sulfoxide (DMSO) or related compounds, or odors associated with same
WO2007033082A2 (en) 2005-09-12 2007-03-22 Abela Pharmaceuticals, Inc. Compositions comprising dimethyl sulfoxide (dmso)
US8480797B2 (en) 2005-09-12 2013-07-09 Abela Pharmaceuticals, Inc. Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors
US7754256B2 (en) * 2007-03-07 2010-07-13 Stan Dennison Nutritional composition
BRPI0921494A2 (pt) * 2008-11-03 2018-10-30 Prad Reasearch And Development Ltd método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração.
CN102548396A (zh) * 2009-04-30 2012-07-04 贝克特里弗里特公司 用于表面消毒的组合物
DK2494059T3 (en) 2009-10-30 2017-02-20 Biogenic Innovations Llc USE OF METHYLSULPHONYLMETHAN (MSM) FOR MODULATING MICROBIAL ACTIVITY
US9839609B2 (en) 2009-10-30 2017-12-12 Abela Pharmaceuticals, Inc. Dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) formulations to treat osteoarthritis
WO2011123695A1 (en) * 2010-03-31 2011-10-06 Abela Pharmaceuticals, Inc. Dimethy sulfoxxide (dmso) formulations for treating autism
MX355103B (es) * 2012-04-02 2018-04-05 Eaglepharma Pty Ltd Composicion para el tratamiento de desordenes inflamatorios e inmunes.
US20160303035A1 (en) * 2014-07-16 2016-10-20 Bio Nano Trinity. Co. Ltd Toothpaste Composition Containing Curcuma Longa L. and Method of Manufacturing Same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL26209A (en) * 1965-08-02 1970-10-30 Merck & Co Inc Pharmaceutical compositions containing substituted sulphones
US4333922A (en) * 1974-09-12 1982-06-08 Herschler R J Method for the treatment of water-living animals with health modifying agents
US4514421A (en) * 1979-08-30 1985-04-30 Herschler R J Dietary and pharmaceutical uses of methylsulfonylmethane and compositions comprising it
US4296130A (en) * 1979-08-30 1981-10-20 Herschler R J Methylsulfonylmethane and methods of use

Also Published As

Publication number Publication date
ATE60234T1 (de) 1991-02-15
US4514421A (en) 1985-04-30
SU1443788A3 (ru) 1988-12-07
NO841909L (no) 1984-05-11
EP0103836A3 (en) 1986-07-30
EP0103836B1 (en) 1991-01-23
WO1984001105A1 (en) 1984-03-29
PH20568A (en) 1987-02-18
AU2039683A (en) 1984-04-04
CA1219218A (en) 1987-03-17
DE3382136D1 (de) 1991-02-28
JPS59501748A (ja) 1984-10-18
AU564536B2 (en) 1987-08-13
DK238384A (da) 1984-05-14
AU599670B2 (en) 1990-07-26
NZ205571A (en) 1986-09-10
EP0103836A2 (en) 1984-03-28
AU7473287A (en) 1987-10-08

Similar Documents

Publication Publication Date Title
DK238384A (da) Farmaceutisk middel indeholdende methylsulfonylmethan
Houston et al. Drug biotransformation interactions in man VI: acetaminophen and ascorbic acid
OA09023A (fr) Composition pharmaceutique, administrable par voie orale, destinée à réduire les effets des b-lactamines.
AU584685B2 (en) Pharmaceutical and dietary compositions
JPS6466159A (en) Vanadyl organic-inorganic compound and manufacture of drug composition containing same
KR910009273A (ko) 위장관계 통증 치료용 약제학적 조성물
US4743596A (en) Anti-arthritic preparation
ES551436A0 (es) Proceso para la fabricacion de compuestos de espiro-hidantoina
KR870002845A (ko) 식욕조절 및 위암억제용 조성물
ES2171459T3 (es) Polvo para administracion nasal de farmaco peptidico o proteinaceo.
KR890009400A (ko) 다이클로닌 Hcl및 페놀을 함유하는 약제학적 조성물
KR910015574A (ko) 3-피로글루타밀-티아졸리딘-4-카르복실산의 유도체 및 그들의 약리학적 작용
ATE44461T1 (de) Analgetische zusammensetzungen.
US4446132A (en) Nontoxic aspirin composition
Abramowitz Papers Presented before the Section of Historical and Cultural Medicine: Historical Points of Interest on the Mode of Action and Ill Effects of Mercury
FR2694005B1 (fr) Nouvelles aminoalkylchromones, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
NO903291L (no) Renin-hemmende aminooligohydroksyderivater.
ATE35536T1 (de) Cystein-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
EP0009046A1 (en) Composition containing salicylsalicyclic acid and acetaminophen
JPS57167912A (en) Antitumor agent
ATE14837T1 (de) Pharmazeutische zusammensetzungen.
KR940011000A (ko) 3β-하이드록시올레안-12-엔-27-오인산 및 그 염을 주성분으로 함유하는 진통제 조성물
KR960033456A (ko) 항스트레스 의약조성물
EA200300007A1 (ru) Композиция для лечения гриппа, способ ее стабилизации
EP0089280A3 (en) Capsule-shape tablet, process and device for its preparation

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment